Evidence map›Paper›PMID 40607420›Full record

ArticleFrontiers in immunology2025

The processed

Chunli Gan, Yuanqiu Mu, Shah Syed Faizan Ali, Xuepeng Shi, Shuang Jiang, Zhengyang Wang, Xiaotian Wu, Xiaotong Wang, Zhibin Wang, Shulu Zhang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Therapeutic Potential of Ziyuglycosides fromDrug design, development and therapy · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chunli Gan *Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Yuanqiu Mu *Department of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Shah Syed Faizan AliDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Xuepeng ShiDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Shuang JiangDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Zhengyang WangDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Xiaotian WuDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Xiaotong WangDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Zhibin WangKey Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese, Harbin, China.
Shulu ZhangDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Zheng FengDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.
Chunjuan YangDepartment of Pharmaceutical Analysis and Analytical Chemistry, College of Pharmacy, Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: The AOM/DSS-induced mouse model of colon cancer was employed to elucidate the mechanism underlying the preventive effects of Results: Conclusion: These results suggest that TP has a more pronounced colon cancer prevention effect than TR. TP play a role in preventing colon cancer by down-regulating TNF-

Indexed as

Colonic NeoplasmsNF-kappa BPlant ExtractsSanguisorbaTriterpenesTumor Necrosis Factor-alphaAnimalsDisease Models, AnimalHumansMaleMiceMolecular Docking SimulationMolecular Dynamics SimulationNetwork PharmacologySignal TransductionNF-kappa BPlant ExtractsTriterpenesTumor Necrosis Factor-alphacolon cancerCOX-2iNOSprocessedSanguisorba officinalis l.TNF-α/NF-κB

Identifiers

PMID40607420
PMCPMC12213563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.